CADENCE NEUROSCIENCE

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.